Annals of Oncology 2018-Jun
HGCSG 1301: A Multicenter, Double-Blind, Randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment.
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard